BWS Financial Inc

BWS provides independent stock specific research focused on companies with distinct value that are going through a special situation where there is a tangible catalyst not priced in. The catalyst can be anything from new product, restructuring, M&A, management change, change in business strategy, etc. BWS’s focus is to understand the change and evaluate the potential return for investors.

BWS utilizes a self formed proprietary approach in discovering stocks by putting great emphasis on deep research. BWS does generate short recommendations following a similar criteria.

Independent Stock Specific Research

IPAR: 2024 in the Spotlight, Target Now $172

Founder, BWS Financial Inc

Hamed Khorsand

Founder

Equity Bottom-Up

<ul>
<li>Since our last update in January 2023, Inter Parfums (IPAR) has released its preliminary fourth quarter sales results and there has been more data affirming consumer demand for fragrances</li>
<li>The reopening of China was earlier than IPAR's management's forecasts, which could have a material boost to sales in 2023.</li>
<li>The addition of Lacoste to the product portfolio remains the catalyst for 2024 sales growth</li>
</ul>


Since our last update in January 2023, Inter Parfums (IPAR) has released its preliminary fourth quarter sales results and there has been more data affirming consumer demand for fragrances
The reopening of China was earlier than IPAR's management's forecasts, which could have a material boost to sales in 2023.
The addition of Lacoste to the product portfolio remains the catalyst for 2024 sales growth


IPAR: Fragrance of a Price Target Increase